<DOC>
	<DOCNO>NCT01002092</DOCNO>
	<brief_summary>Purpose : This study ass safety efficacy Endostar combine chemotherapy osteosarcoma patient .</brief_summary>
	<brief_title>A Study Endostar Combined With Chemotherapy Treatment Osteosarcoma</brief_title>
	<detailed_description />
	<mesh_term>Osteosarcoma</mesh_term>
	<criteria>Patients histologically confirm osteosarcoma , evidence metastasis At least one measurable lesion Life expectancy &gt; 3 month ECOG performance status 02 Adequate hematologic , cardiac , renal , hepatic function Patients prior chemotherapy least 4 week clearance period enter study Evidence metastasis Serious infection Evidence bleed diathesis Significant cardiovascular disease Pregnant lactate woman Allergic E.coli preparation</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Osteosarcoma</keyword>
	<keyword>Endostar</keyword>
	<keyword>Chemotherapy</keyword>
</DOC>